ICU Medical, Inc. (ICUI)
Largest Insider Buys in Sector
ICUI Stock Price History Chart
ICUI Stock Performance
About ICU Medical, Inc.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana …
Insider Activity of ICU Medical, Inc.
Over the last 12 months, insiders at ICU Medical, Inc. have bought $0 and sold $193.96M worth of ICU Medical, Inc. stock.
On average, over the past 5 years, insiders at ICU Medical, Inc. have bought $1.23M and sold $60.1M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,092 shares for transaction amount of $1.23M was made by LOPEZ GEORGE A () on 2022‑05‑12.
List of Insider Buy and Sell Transactions, ICU Medical, Inc.
| 2024-11-01 | Sale | Chairman and CEO | 12,000 0.0494% | $171.84 | $2.06M | +2.92% | ||
| 2024-10-01 | Sale | Chairman and CEO | 12,000 0.0503% | $178.47 | $2.14M | -0.59% | ||
| 2024-09-03 | Sale | Chairman and CEO | 12,000 0.0492% | $163.46 | $1.96M | +8.51% | ||
| 2024-08-30 | Sale | VP, GM-Infusion Capital | 2,502 0.0101% | $163.22 | $408,370 | +7.01% | ||
| 2024-08-16 | Sale | Chairman and CEO | 12,000 0.0516% | $156.04 | $1.87M | -0.12% | ||
| 2024-08-08 | Sale | VP, General Counsel | 2,050 0.0081% | $144.11 | $295,426 | +15.67% | ||
| 2024-05-30 | Sale | Chief Operating Officer | 12,539 0.0517% | $103.95 | $1.3M | +57.94% | ||
| 2024-05-16 | Sale | director | 300 0.0012% | $104.95 | $31,484 | +52.65% | ||
| 2024-05-10 | Sale | Chief Information Officer | 2,000 0.0081% | $105.55 | $211,090 | +49.49% | ||
| 2024-03-15 | Sale | VP, GM-Infusion Capital | 791 0.0033% | $98.27 | $77,733 | +22.86% | ||
| 2024-03-14 | Sale | director | 7,978 0.0333% | $101.87 | $812,741 | +21.75% | ||
| 2024-03-12 | Sale | director | 1,522 0.0063% | $101.51 | $154,497 | +18.72% | ||
| 2024-03-11 | Sale | director | 1,890 0.0079% | $104.22 | $196,968 | +15.42% | ||
| 2024-03-08 | Sale | director | 15,372 0.0643% | $105.94 | $1.63M | +13.78% | ||
| 2024-03-08 | Sale | VP, General Counsel | 3,300 0.0136% | $104.57 | $345,088 | +13.78% | ||
| 2024-03-07 | Sale | director | 18,954 0.0792% | $105.77 | $2M | +12.45% | ||
| 2024-03-04 | Sale | director | 7,051 0.0292% | $106.79 | $752,993 | +9.31% | ||
| 2024-03-04 | Sale | Chief Operating Officer | 13,603 0.0565% | $107.19 | $1.46M | +9.31% | ||
| 2024-02-29 | Sale | Former 10% Owner | 830,000 3.3087% | $106.08 | $88.04M | +6.64% | ||
| 2024-02-29 | Sale | Former 10% Owner | 830,000 3.3087% | $106.08 | $88.04M | +6.64% |
Insider Historical Profitability
| LOPEZ GEORGE A | director | 877343 3.5833% | $167.73 | 9 | 248 | +23.53% |
| Jain Vivek | Chairman and CEO | 104593 0.4272% | $167.73 | 1 | 28 | +6.49% |
| SHERMAN RICHARD MD | director | 69199 0.2826% | $167.73 | 1 | 16 | |
| SWINNEY ROBERT S | director | 20816 0.085% | $167.73 | 1 | 34 | |
| BROWN JACK | director | 16813 0.0687% | $167.73 | 1 | 3 |
Institutional Investor Ownership
| BlackRock | $278.48M | 10.65 | 2.59M | +1.42% | +$3.89M | 0.01 | |
| Janus Henderson | $265.24M | 10.14 | 2.47M | -5.59% | -$15.72M | 0.13 | |
| The Vanguard Group | $263.23M | 10.07 | 2.45M | +0.49% | +$1.29M | 0.01 | |
| Fuller & Thaler Asset Management, Inc. | $164.71M | 6.3 | 1.53M | +4.26% | +$6.73M | 0.72 | |
| Wellington Management Company | $148.01M | 5.66 | 1.38M | -12.46% | -$21.06M | 0.03 |